PhaseBio Pharmaceuticals

NasdaqGM:PHAS Stock Report

Mkt Cap: US$9.4m

PhaseBio Pharmaceuticals Company Information

PhaseBio Pharmaceuticals, Inc.'s employee growth, exchange listings and data sources

Key Information

  • Name: PhaseBio Pharmaceuticals, Inc.
  • Ticker: PHAS
  • Exchange: NasdaqGM
  • Founded: 2002
  • Industry: Biotechnology
  • Sector: Pharmaceuticals & Biotech
  • Implied Market Cap: US$9.398m
  • Shares outstanding: 49.86m
  • Website:

Number of Employees


  • PhaseBio Pharmaceuticals, Inc.
  • 1 Great Valley Parkway
  • Suite 30
  • Malvern
  • Pennsylvania
  • 19355
  • United States


TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
PHASNasdaqGM (Nasdaq Global Market)YesCommon StockUSUSDOct 2018
2K4DB (Deutsche Boerse AG)YesCommon StockDEEUROct 2018

Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2022/10/04 00:00
End of Day Share Price2022/10/04 00:00
Annual Earnings2021/12/31

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.